Flynn Zito Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.57M Hold
2,144
0.7% 31
2026
Q1
$1.97M Buy
2,144
+1
+0% +$1.01K 0.63% 34
2025
Q4
$2.3M Buy
2,143
+1,157
+117% +$1.11M 0.82% 23
2025
Q3
$753K Sell
986
-5
-0.5% -$3.72K 0.28% 57
2025
Q2
$773K Buy
991
+647
+188% +$503K 0.33% 50
2025
Q1
$285K Hold
344
0.13% 88
2024
Q4
$266K Hold
344
0.12% 92
2024
Q3
$305K Buy
344
+6
+2% +$5.39K 0.15% 76
2024
Q2
$306K Hold
338
0.16% 70
2024
Q1
$263K Buy
+338
New +$241K 0.14% 85

Other funds holding LLY

Flynn Zito Capital Management's LLY Position: Q2 2026 in Review

Flynn Zito Capital Management held its Eli Lilly (LLY) position steady in Q2 2026 at 2,144 shares worth $2.57M. The position accounts for 0.7% of the portfolio, ranked #31.

Flynn Zito Capital Management first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Flynn Zito Capital Management held 2,144 shares of Eli Lilly worth $2.57M as of Q2 2026.
  • Flynn Zito Capital Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.7% of Flynn Zito Capital Management's portfolio in Q2 2026, its #31 holding.
  • Flynn Zito Capital Management first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Flynn Zito Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.